Black Diamond Therapeutics, Inc. (BDTX) vs Immunic, Inc. (IMUX)
A side-by-side comparison of Black Diamond Therapeutics, Inc. and Immunic, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BDTX
Black Diamond Therapeutics, Inc.
$1.90HealthcareDelayed quote: Oct 6, 2026, 10:05 AM EDT
IMUX
Immunic, Inc.
$8.14HealthcareDelayed quote: Oct 6, 2026, 10:04 AM EDT
Total return — BDTX vs IMUX
growth of $100 · dividends reinvested · last 7yBDTX -95.1% (-35.0%/yr)IMUX -90.3% (-28.4%/yr)IMUX compounded faster over this window
BDTX IMUX
BDTX vs IMUX: by the numbers
- •IMUX is the larger company ($111M vs $109M market cap).
- •BDTX is profitable (31.95% net margin) while IMUX runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | BDTX | IMUX |
|---|---|---|
| P/B ratio | 1.13 | 0.87 |
Profitability
| Metric | BDTX | IMUX |
|---|---|---|
| Gross margin | 99.54% | 0.00% |
| Operating margin | 28.39% | 0.00% |
| Net margin | 31.95% | 0.00% |
| ROE | -44.29% | -87.45% |
| ROIC | -47.54% | -92.16% |
Growth (annualized)
| Metric | BDTX | IMUX |
|---|---|---|
| Total return CAGR (5Y) | -24.47% | -35.70% |
Frequently asked
- Is BDTX or IMUX more profitable?
- BDTX runs the higher net margin — BDTX at 31.95% versus IMUX at 0.00%.
- How have BDTX and IMUX total returns compared?
- Over the past 5 years, BDTX delivered -24.47% and IMUX delivered -35.70% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.